Liminatus Pharma, Inc. (LIMN)
0.792
-0.02
(-2.21%)
USD |
NASDAQ |
Dec 19, 16:00
0.81
+0.02
(+2.27%)
After-Hours: 16:38
Liminatus Pharma Shareholders Equity (Annual): -15.87M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| CDT Equity, Inc. | -6.793M |
| LENZ Therapeutics, Inc. | 204.08M |
| Oruka Therapeutics, Inc. | 382.22M |
| Maze Therapeutics, Inc. | 196.90M |
| MapLight Therapeutics, Inc. | -- |